Drawing for OPHTHA FUTUR

USPTO serial 79201974

OPHTHA FUTUR

Reviewed by CopyMark Law Group

Reg. 5372133Status 709
Filing date
Status date
Registration date
Jan 9, 2018
Examiner
PARKS, KIMBERLY L
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with OPHTHA FUTUR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Paul D. Bianco

Paul D. Bianco Fleit Gibbons Gutman Bongini & Bianco PL21355 East Dixie HighwaySuite 115Miami, FL 33180

Goods and services

ClassDescriptionStatusFirst use
005Medicine, in particular ophthalmologic preparations; ocular pharmaceuticals, pharmaceuticals to support ophthalmic surgerySECTION 71 - CANCELLED—
010Surgical, medical, dental and veterinary apparatus and instruments for use in ophthalmic treatment and ophthalmic surgery, cataract removal equipment, vitrectomy equipment and endoscopes; artificial limbs; artificial eyes; artificial teeth; orthopedic articles, namely, silicone orthopedic devices for therapeutic use, silicone orthopedic implants, pillows and compression pads for orthopedic use, elastic bandages and plaster bandages for orthopedic purposes, synthetic supportive bandages and orthopedic support bandages; suture materialsSECTION 71 - CANCELLED—
042Scientific and technological services, namely, scientific research, analysis, testing, quality management building and product development, in the field of treatment of eye diseases and ophthalmic surgery; research relating to technology, in particular chemical technological research; advisory services relating to technological research in the field of chemical, physical, biological and technological research for the development of ophthalmic drugs and medical devices; provision of information relating to technological research in the field of ophthalmic pharmaceuticals, materials and medical devices used in ophthalmology; technological services in the field of ophthalmology, namely, technological consultation, technological information, product development, development of manufacturing equipment used for ophthalmic drugs and products and advisory in the field of site planning for manufacturing of ophthalmic devices; chemical research; chemical research and analysis services; research on the subject of pharmaceuticals; pharmaceutical drug development services; pharmaceutical research and development; medical and pharmaceutical research and development; consultancy pertaining to pharmacology, in particular ophthalmology; conducting clinical trials for pharmaceutical products; product evaluations and product registration, reports and post market follow up of ophthalmic products in international markets, evaluations of scientific projects related to the ophthalmic industry services for assessing the efficiency of pharmaceuticals, planning and management of quality relevant activities in the field of ophthalmic manufacturing; research and development for the pharmaceutical industry; providing information about the results of clinical trials for pharmaceutical products; information technology consultancy services for the pharmaceutical and healthcare industries; all aforementioned services particularly relating to ophthalmology and ophthalmologic preparationsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 11, 2025INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jun 24, 2025INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jun 24, 2025INPCINVALIDATION PROCESSED—
Mar 26, 2025INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jul 26, 2024C71TCANCELLED SECTION 71—
Jan 9, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Oct 5, 2018NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 1, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 17, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 17, 2018FIMPFINAL DISPOSITION PROCESSED—
Apr 9, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 9, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 24, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 24, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 21, 2017GPNXNOTIFICATION PROCESSED BY IB—
Oct 4, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 4, 2017OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Oct 4, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 12, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 7, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 7, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 7, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 25, 2017RFNTREFUSAL PROCESSED BY IB—
Mar 7, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 7, 2017RFRRREFUSAL PROCESSED BY MPU—
Mar 7, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 6, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 28, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 24, 2017DOCKASSIGNED TO EXAMINER—
Feb 24, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 23, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance